Cargando…
Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma
Medullary thyroid carcinoma (MTC) is a malignancy derived from the calcitonin-producing C-cells of the thyroid gland. Oncogenic mutations of the Ret proto-oncogene are found in all heritable forms of MTC and roughly one half of the sporadic cases. However, several lines of evidence argue for the exi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378485/ https://www.ncbi.nlm.nih.gov/pubmed/22158037 http://dx.doi.org/10.1038/onc.2011.556 |
_version_ | 1782236044508266496 |
---|---|
author | Macià, Anna Gallel, Pilar Vaquero, Marta Gou-Fabregas, Myriam Santacana, Maria Maliszewska, Agnieszka Robledo, Mercedes Gardiner, Jennifer R. Basson, M. Albert Matias-Guiu, Xavier Encinas, Mario |
author_facet | Macià, Anna Gallel, Pilar Vaquero, Marta Gou-Fabregas, Myriam Santacana, Maria Maliszewska, Agnieszka Robledo, Mercedes Gardiner, Jennifer R. Basson, M. Albert Matias-Guiu, Xavier Encinas, Mario |
author_sort | Macià, Anna |
collection | PubMed |
description | Medullary thyroid carcinoma (MTC) is a malignancy derived from the calcitonin-producing C-cells of the thyroid gland. Oncogenic mutations of the Ret proto-oncogene are found in all heritable forms of MTC and roughly one half of the sporadic cases. However, several lines of evidence argue for the existence of additional genetic lesions necessary for the development of medullary thyroid carcinoma. Sprouty (Spry) family of genes is composed of four members in mammals (Spry1-4). Some Spry family members have been proposed as candidate tumor suppressor genes in a variety of cancerous pathologies. In this work, we show that targeted deletion of Spry1 causes C-cell hyperplasia, a precancerous lesion preceding MTC, in young adult mice. Expression of Spry1 restrains proliferation of the MTC-derived cell line, TT. Finally, we found that the Spry1 promoter is frequently methylated in MTC and that Spry1 expression is consequently decreased. These findings identify Spry1 as a candidate tumor suppressor gene in medullary thyroid carcinoma. |
format | Online Article Text |
id | pubmed-3378485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-33784852013-02-28 Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma Macià, Anna Gallel, Pilar Vaquero, Marta Gou-Fabregas, Myriam Santacana, Maria Maliszewska, Agnieszka Robledo, Mercedes Gardiner, Jennifer R. Basson, M. Albert Matias-Guiu, Xavier Encinas, Mario Oncogene Article Medullary thyroid carcinoma (MTC) is a malignancy derived from the calcitonin-producing C-cells of the thyroid gland. Oncogenic mutations of the Ret proto-oncogene are found in all heritable forms of MTC and roughly one half of the sporadic cases. However, several lines of evidence argue for the existence of additional genetic lesions necessary for the development of medullary thyroid carcinoma. Sprouty (Spry) family of genes is composed of four members in mammals (Spry1-4). Some Spry family members have been proposed as candidate tumor suppressor genes in a variety of cancerous pathologies. In this work, we show that targeted deletion of Spry1 causes C-cell hyperplasia, a precancerous lesion preceding MTC, in young adult mice. Expression of Spry1 restrains proliferation of the MTC-derived cell line, TT. Finally, we found that the Spry1 promoter is frequently methylated in MTC and that Spry1 expression is consequently decreased. These findings identify Spry1 as a candidate tumor suppressor gene in medullary thyroid carcinoma. 2011-12-12 2012-08-30 /pmc/articles/PMC3378485/ /pubmed/22158037 http://dx.doi.org/10.1038/onc.2011.556 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Macià, Anna Gallel, Pilar Vaquero, Marta Gou-Fabregas, Myriam Santacana, Maria Maliszewska, Agnieszka Robledo, Mercedes Gardiner, Jennifer R. Basson, M. Albert Matias-Guiu, Xavier Encinas, Mario Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title | Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title_full | Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title_fullStr | Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title_full_unstemmed | Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title_short | Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
title_sort | sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378485/ https://www.ncbi.nlm.nih.gov/pubmed/22158037 http://dx.doi.org/10.1038/onc.2011.556 |
work_keys_str_mv | AT maciaanna sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT gallelpilar sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT vaqueromarta sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT goufabregasmyriam sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT santacanamaria sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT maliszewskaagnieszka sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT robledomercedes sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT gardinerjenniferr sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT bassonmalbert sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT matiasguiuxavier sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma AT encinasmario sprouty1isacandidatetumorsuppressorgeneinmedullarythyroidcarcinoma |